Drug intelligence / Profile preview

Neuridan

Development stage
Unknown
Lead developer
NeuroEnergy Ventures
Modality
Small Molecules
Administration
Oral
01

Overview

Neuridan is a medical food developed by NeuroEnergy Ventures for the dietary management of mild cognitive impairment (MCI) and mild-to-moderate Alzheimer's Disease. The product's active ingredient is a ketone ester, specifically glyceryl 3-hydroxybutyrate ester (also known as ketogenic glyceryl 3-hydroxybutyrate ester). Neuridan is designed to address the 'brain energy gap'—a condition in neurodegenerative diseases where the brain's ability to metabolize glucose is impaired. By providing ketone bodies as an alternative energy substrate, Neuridan supports brain nutrition and enables patients to maintain physiological hyperketonemia without the gastrointestinal side effects often associated with medium-chain triglycerides (MCTs) or ketone salts. It is administered orally under medical supervision as part of a comprehensive disease management plan.

Brand names
Neuridan
Other names
glyceryl 3-hydroxybutyrate esterglyceryl3-hydroxybutyrate esterglyceryl-3-hydroxybutyrate esterketogenic glyceryl 3-hydroxybutyrate esterketone ester

Beyond the preview

Go deeper on Neuridan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuridan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call